Clinical study of FOLFOX4 regimen for patients of advanced hepatocellular carcinoma
Conclusionnbsp;nbsp;FOLFOX4 regimen is effective and safe for patients with advanced primary hepatocellular carcinoma. It can be worthy of further clinical investigation. Content Type Journal ArticlePages 134-137DOI 10.1007/s10330-011-0934-0Authors Hua Zhu, Department of Oncology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University Medical College, Yantai, 264000 ChinaPing Sun, Department of Oncology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University Medical College, Yantai, 264000 China Journal The Chinese-German Journal of Clinical OncologyOnline ISSN 1613-9089Print ISSN 1610-1979 Journal Volume Volume 11 Journal Issue Volume 11, Number 3 (Source: The Chinese-German Journal of Clinical Oncology)

Reply
We thank Professor Oguz for commenting on our paper. While dysesthetic blebs following glaucoma drainage surgery contribute to symptomatic ocular surface disease (OSD), there is little data regarding the specific etiology. It is likely to be multifactorial. Budenz and associates, investigating 97 patients with unilateral trabeculectomy blebs, found that young age, bleb exposure in the interpalpebral fissure, height of the bleb adjacent to the cornea, and bubbles in the tear film on blinking were predictive of dysesthesia. Only 2 patients had adjacent dellen and 6 an epithelial defect; hence, no significant results were obtained regarding these proposed mechanisms. Surprisingly, the type of antifibrotic agent used (none, 5-fluorouracil, or mitomycin C) was not predictive of dysesthesia, as ...